Lasker Winners Announced

DNA-damage response and cancer immunotherapy discoveries are among those recognized by the Albert and Mary Lasker Foundation this year.

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Left to right: Stephen Elledge, Evelyn Witkin, James AllisonALBERT AND MARY LASKER FOUNDATIONEvelyn Witkin of Rutgers University in New Jersey and Stephen Elledge of the Brigham and Women’s Hospital in Boston have won the 2015 Lasker Award for basic medical research. The Albert and Mary Lasker Foundation is recognizing Witkin and Elledge for their pioneering work on the DNA-damage response. (See “Gene Silencing Is Golden,” The Scientist, August 2013; “Damage Control,” The Scientist, March 2009.)

The University of Texas MD Anderson Cancer Center’s James Allison has won the 2015 Lasker Award for clinical medical research. He is being honored for his work toward antibody-based immunotherapies for cancer. (See “Deploying the Body’s Army,” The Scientist, April 2014.)

“I’ve always considered [my work] really basic science, so it’s really quite an honor to receive the clinical award this year,” Allison said during a press conference today (September 8). “I see it in part as an acknowledgement of advances in immunotherapy . . . as a field.”

Médecins Sans Frontières (MSF, also known as Doctors Without Borders) has won this year’s Lasker-Bloomberg Public Service Award for “bold leadership in responding to the recent Ebola outbreak in Africa, and for sustained and effective frontline ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Tracy Vence

    This person does not yet have a bio.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo
Characterizing Immune Memory to COVID-19 Vaccination

Characterizing Immune Memory to COVID-19 Vaccination

10X Genomics
Optimize PCR assays with true linear temperature gradients

Applied Biosystems™ VeriFlex™ System: True Temperature Control for PCR Protocols

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo